Azitra Inc (AZTR) - Revenue and Sales Volume

Azitra, Inc. (AZTR) develops gene therapies using microbiome proteins to combat dermatological diseases, diversifying risks through a broad pipeline. The absence of sanction threats and operations within US jurisdiction provide a neutral backdrop. The company's sales profile visualizes the market consensus, where 0.00 characterizes this valuation parameter. Business stability is based on the monetization of a unique bacterial drug platform.

AZTR (Azitra, Inc.) Revenue and Sales Volume history from 02/21/2024 to 11/13/2026

Analytical breakdowns for Azitra, Inc.

- current price and projected stock value:

Share Price Azitra Corporation|AZTR - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization Azitra, Inc.|AZTR - Real Price to Acquire Entire Company

- company book value details:

Share Book Value Azitra|AZTR - Book Capitalization|Market Capitalization to Book Value azitrainc.com|AZTR - Cumulative Company Assets

- debt obligations and liquidity statistics:

- net income and valuation multiples indicators:

AZTR - Company Net Income|Net Profit Forecast Azitra, Inc.|AZTR - P/E Multiple|Projected Price to Earnings azitrainc.com|AZTR - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Azitra, Inc.|AZTR - Operating profit EBITDA|Net earnings per share (EPS TTM) Azitra|AZTR - Net earnings per share for the last 12 months|Year-over-year net earnings per share trend for the last twelve months azitrainc.com|AZTR - Net earnings per share growth this year|Projected earnings per share increase next year Azitra, Inc.

- company sales and revenue statistics:

AZTR - Company Revenue|Company Future Revenue Azitra Corporation|AZTR - Price-to-Revenue Ratio|Future Price to Revenue Azitra, Inc.

Summary company analysis:AZTR, Azitra Corporation

Daily revenue monitoring allows for the precise determination of the rate of decline in operating cash flows, preventing the purchase of an overvalued asset at its peak market value. By analyzing the sales dynamics of Azitra, Inc. (AZTR), an investor assesses the effectiveness of the commercialization of its developments, where the flexible allocation of the R&D budget among external laboratories directly impacts product implementation rates and the overall financial stability of the biotech firm.

Competing companies